Active ingredient
Ranibizumab NDC Codes
Ranibizumab is an active ingredient in 11 finished products listed with the FDA, under 5 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Labelers
- Genentech, Inc., Zydus Pharmaceuticals USA Inc., Sandoz Inc, Coherus BioSciences Inc, Harrow Eye, LLC, BIOGEN INC.
- Strengths
- Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Ranibizumab 10 mg/mL; Ranibizumab 100 mg/mL; Ranibizumab 6 mg/mL
- Dosage forms
- Injection, Solution
- Routes
- Intravitreal
- Drug classes (FDA established)
- Vascular Endothelial Growth Factor Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 15
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Nufymcoranibizumab-leyk | Ranibizumab .3 mg/.05mL | Injection, SolutionIntravitreal | Zydus Pharmaceuticals USA Inc. | 70710-2172 | 70710-2172-01 | J2778 |
| Nufymcoranibizumab-leyk | Ranibizumab .5 mg/.05mL | Injection, SolutionIntravitreal | Zydus Pharmaceuticals USA Inc. | 70710-2173 | 70710-2173-01 | J2778 |
| Byoovizranibizumab-nuna | Ranibizumab 10 mg/mL | Injection, SolutionIntravitreal | Harrow Eye, LLC | 82667-018 | 82667-0018-05 | J2778 |
| Cimerliranibizumab-eqrn | Ranibizumab .3 mg/.05mL | Injection, SolutionIntravitreal | Sandoz Inc | 61314-624 | 61314-0624-94 | J2778 |
| Cimerliranibizumab-eqrn | Ranibizumab .5 mg/.05mL | Injection, SolutionIntravitreal | Sandoz Inc | 61314-625 | 61314-0625-94 | J2778 |
| Cimerliranibizumab-eqrn | Ranibizumab .3 mg/.05mL | Injection, SolutionIntravitreal | Coherus BioSciences Inc | 70114-440 | 70114-0440-01 | J2778 |
| Cimerliranibizumab-eqrn | Ranibizumab .5 mg/.05mL | Injection, SolutionIntravitreal | Coherus BioSciences Inc | 70114-441 | 70114-0441-01 | J2778 |
| Byoovizranibizumab-nuna | Ranibizumab 10 mg/mL | Injection, SolutionIntravitreal | BIOGEN INC. | 64406-019 | 64406-0019-0164406-0019-08 | J2778 |
| Susvimoranibizumab | Ranibizumab 100 mg/mL | Injection, SolutionIntravitreal | Genentech, Inc. | 50242-078 | 50242-0078-1250242-0078-55 | J2778 |
| Lucentisranibizumab | Ranibizumab 6 mg/mL | Injection, SolutionIntravitreal | Genentech, Inc. | 50242-082 | 50242-0082-0350242-0082-88 | J2778 |
| Lucentisranibizumab | Ranibizumab 10 mg/mL | Injection, SolutionIntravitreal | Genentech, Inc. | 50242-080 | 50242-0080-0350242-0080-88 | J2778 |
Ranibizumab: common questions
- Which drugs contain Ranibizumab?
- Cimerli, Nufymco, Byooviz, Lucentis, Susvimo.
- Is there a J-code for Ranibizumab?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.